Direkt zum Inhalt
Merck
  • Type II NADH dehydrogenase of the respiratory chain of Plasmodium falciparum and its inhibitors.

Type II NADH dehydrogenase of the respiratory chain of Plasmodium falciparum and its inhibitors.

Bioorganic & medicinal chemistry letters (2008-12-23)
Carolyn K Dong, Vishal Patel, Jimmy C Yang, Jeffrey D Dvorin, Manoj T Duraisingh, Jon Clardy, Dyann F Wirth
ZUSAMMENFASSUNG

Plasmodium falciparum NDH2 (pfNDH2) is a non-proton pumping, rotenone-insensitive alternative enzyme to the multi-subunit NADH:ubiquinone oxidoreductases (Complex I) of many other eukaryotes. Recombinantly expressed pfNDH2 prefers coenzyme CoQ(0) as an acceptor substrate, and can also use the artificial electron acceptors, menadione and dichlorophenol-indophenol (DCIP). Previously characterized NDH2 inhibitors, dibenziodolium chloride (DPI), diphenyliodonium chloride (IDP), and 1-hydroxy-2-dodecyl-4(1H)quinolone (HDQ) do not inhibit pfNDH2 activity. Here, we provide evidence that HDQ likely targets another P. falciparum mitochondrial enzyme, dihydroorotate dehydrogenase (pfDHOD), which is essential for de novo pyrimidine biosynthesis.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Rotenon, ≥95%
Sigma-Aldrich
Menadion, crystalline
Sigma-Aldrich
Menadion, meets USP testing specifications
Supelco
Menadion (K3), analytical standard
Sigma-Aldrich
Diphenyliodonium-hexafluorophosphat, ≥98%
Sigma-Aldrich
Indophenol
Sigma-Aldrich
Diphenyliodonium-chlorid, ≥98.0% (AT)
Sigma-Aldrich
Flavon, ≥99.0%
Supelco
Rotenon, PESTANAL®, analytical standard
Sigma-Aldrich
Diphenyliodoniumnitrat